Drug
Evetifator clinical trials
Also written DNL343.
- studies test it
- 6
- open now
- 0
- in phase 3
- 2
- first study started
- 2020
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 2
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 2
Often tested with
Tested in the same studies.
Zilucoplan (1) · AZD3241 (1) · CNM-Au8 (1) · Pridopidine (1) · SLS-005 (1) · Fosigotifator sodium tromethamine (1) · Fosigotifator (1) · NUZ-001 (1)
Studies
Open first, then newest update. How each study uses evetifator is read from its arms, and is right about nine times in ten.
Testing it · 6
- HEALEY ALS Platform Trial - Master ProtocolActive, not recruitingPhase 2/3Merit E. Cudkowicz, MDNCT04297683Written as DNL343
- HEALEY ALS Platform Trial - Regimen G DNL343CompletedPhase 2/3Merit E. Cudkowicz, MDNCT05842941Written as DNL343
- A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral SclerosisCompletedPhase 1Denali Therapeutics Inc.NCT05006352Written as DNL343
- A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-DNL343 Following a Single Oral Dose in Healthy Male ParticipantsCompletedPhase 1Denali Therapeutics Inc.NCT06281158Written as [14C]-DNL343
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy VolunteersCompletedPhase 1Denali Therapeutics Inc.NCT04268784Written as DNL343
- A Study to Evaluate the Bioavailability and Safety of DNL343 in Healthy VolunteersCompletedPhase 1Denali Therapeutics Inc.NCT04581772Written as DNL343
Codes
What other systems call evetifator · ClinicalTrials.gg INT016607
- UNII (FDA) FYL3Y9D7SKEVETIFATOROne source FDA
- NCI Thesaurus C211771EvetifatorOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | FYL3Y9D7SK | EVETIFATOR | One source FDA |
| NCI Thesaurus | C211771 | Evetifator | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.